AVN 68.30 Increased By ▲ 0.55 (0.81%)
BAFL 31.06 Increased By ▲ 0.08 (0.26%)
BOP 4.93 Increased By ▲ 0.12 (2.49%)
CNERGY 3.90 Increased By ▲ 0.14 (3.72%)
DFML 13.93 Decreased By ▼ -0.05 (-0.36%)
DGKC 42.80 Increased By ▲ 1.80 (4.39%)
EPCL 47.77 Increased By ▲ 0.72 (1.53%)
FCCL 12.10 Increased By ▲ 0.45 (3.86%)
FFL 5.30 Increased By ▲ 0.14 (2.71%)
FLYNG 6.25 Increased By ▲ 0.31 (5.22%)
GGL 11.08 Decreased By ▼ -0.21 (-1.86%)
HUBC 66.94 Decreased By ▼ -1.01 (-1.49%)
HUMNL 5.87 Increased By ▲ 0.17 (2.98%)
KAPCO 28.02 Decreased By ▼ -0.02 (-0.07%)
KEL 2.36 Increased By ▲ 0.09 (3.96%)
LOTCHEM 26.55 Increased By ▲ 0.35 (1.34%)
MLCF 22.55 Increased By ▲ 0.89 (4.11%)
NETSOL 87.40 Increased By ▲ 0.95 (1.1%)
OGDC 107.16 Increased By ▲ 6.67 (6.64%)
PAEL 11.45 Increased By ▲ 0.30 (2.69%)
PIBTL 4.27 Increased By ▲ 0.03 (0.71%)
PPL 84.70 Increased By ▲ 4.10 (5.09%)
PRL 13.66 Increased By ▲ 0.43 (3.25%)
SILK 0.95 Increased By ▲ 0.04 (4.4%)
SNGP 45.39 Increased By ▲ 1.49 (3.39%)
TELE 6.21 Increased By ▲ 0.14 (2.31%)
TPLP 16.07 Increased By ▲ 0.22 (1.39%)
TRG 123.90 Increased By ▲ 2.32 (1.91%)
UNITY 14.31 Increased By ▲ 0.31 (2.21%)
WTL 1.33 Increased By ▲ 0.01 (0.76%)
BR100 4,276 Increased By 95.2 (2.28%)
BR30 15,683 Increased By 412.9 (2.7%)
KSE100 42,467 Increased By 743.3 (1.78%)
KSE30 16,021 Increased By 275.4 (1.75%)
Business & Finance AGP (AGP Limited) 63.01 Increased By ▲ 4.67%

Pakistani pharma announces to ensure availability of Sputnik V vaccine

  • The Drug Regulatory Authority of Pakistan (DRAP) on February 1st 2021 granted Emergency Use Authorisation (EUA) for ‘Gam-Covid-Vac’ combined vector vaccine to prevent coronavirus infection caused by SARS CoV-2 virus.
Published February 2, 2021
Follow us

AGP Limited, the Pakistani pharmaceutical company authorised to import and introduce the ‘Sputnik V’ vaccine in Pakistan has said that it is now making efforts to ensure the availability of sufficient supplies of vaccine on an emergency basis.

The Drug Regulatory Authority of Pakistan (DRAP) on February 1st 2021 granted Emergency Use Authorisation (EUA) for ‘Gam-Covid-Vac’ combined vector vaccine to prevent coronavirus infection caused by SARS CoV-2 virus.

The vaccine has been developed by the Gamaleya National Centre of Epidemiology and Microbiology, Russia one of the world's leading research institutions. This vaccine has been approved by 15 countries including Russia, Hungary, Argentina and the United Arab Emirates with registrations underway in several other countries.

“As per the Interim Clinical Study Report which is based on the Phase III trials of 21,862 volunteers the efficacy of Sputnik V has been determined at 91.6% with 100% efficacy against severe cases of COVID-19. The vaccine has a good safety profile and in particular there are no strong allergy is caused by the vaccine,” stated the pharma.

“This is by far the most effective COVID-19 vaccine to have received EUA in Pakistan and can be administered two persons aged 18 and above including persons aged above 60,” it added.

Comments

Comments are closed.

Pakistani pharma announces to ensure availability of Sputnik V vaccine

Intra-day update: Bullish run at PSX, KSE-100 up over 800 points

Rupee gains 1.04%, closes at 270.51 against US dollar

Pak Suzuki raises car prices for second time in a month

Not received LHC order suspending resignations of 43 PTI MNAs: NA speaker

Qatar agrees to buy OGDCL, PPL shares

Islamabad court rejects Sheikh Rashid’s second post-arrest bail

Most of country’s PSEs ripe for sale or closure?

India says debt talks in focus at G20 finance meet

IMF talks: ‘Some understanding’ reached: MoS Pasha

PM forms body to activate STZA